Although future studies are required to delineate the key endogenous ligands and downstream signaling pathways of GPRC5B, the present study underscores the importance of this orphan receptor in the development of lymphatics and lays the foundation for exploring the utility of this and other lymphatic-enriched orphan GPCRs as potential therapeutic targets for lymphatic disorders. This evidence concerns the gene GPRC5B and lymphatic system disorder.